chr11-112228687-T-C

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The ENST00000525645.1(PTS):​n.252T>C variant causes a non coding transcript exon change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.152 in 1,600,344 control chromosomes in the GnomAD database, including 21,332 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.12 ( 1451 hom., cov: 32)
Exomes 𝑓: 0.16 ( 19881 hom. )

Consequence

PTS
ENST00000525645.1 non_coding_transcript_exon

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:5

Conservation

PhyloP100: 0.186

Publications

15 publications found
Variant links:
Genes affected
PTS (HGNC:9689): (6-pyruvoyltetrahydropterin synthase) The enzyme encoded by this gene catalyzes the elimination of inorganic triphosphate from dihydroneopterin triphosphate, which is the second and irreversible step in the biosynthesis of tetrahydrobiopterin from GTP. Tetrahydrobiopterin, also known as BH(4), is an essential cofactor and regulator of various enzyme activities, including enzymes involved in serotonin biosynthesis and NO synthase activity. Mutations in this gene result in hyperphenylalaninemia. [provided by RefSeq, Oct 2008]
PTS Gene-Disease associations (from GenCC):
  • BH4-deficient hyperphenylalaninemia A
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: G2P, ClinGen, Orphanet, Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.85).
BP6
Variant 11-112228687-T-C is Benign according to our data. Variant chr11-112228687-T-C is described in ClinVar as Benign. ClinVar VariationId is 302498.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (SAS) allele frequency at 95% confidence interval = 0.33 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
PTSNM_000317.3 linkc.163+14T>C intron_variant Intron 2 of 5 ENST00000280362.8 NP_000308.1 Q03393

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
PTSENST00000280362.8 linkc.163+14T>C intron_variant Intron 2 of 5 1 NM_000317.3 ENSP00000280362.3 Q03393

Frequencies

GnomAD3 genomes
AF:
0.120
AC:
18147
AN:
151806
Hom.:
1445
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0283
Gnomad AMI
AF:
0.124
Gnomad AMR
AF:
0.127
Gnomad ASJ
AF:
0.129
Gnomad EAS
AF:
0.258
Gnomad SAS
AF:
0.342
Gnomad FIN
AF:
0.140
Gnomad MID
AF:
0.0796
Gnomad NFE
AF:
0.144
Gnomad OTH
AF:
0.112
GnomAD2 exomes
AF:
0.166
AC:
41463
AN:
249736
AF XY:
0.174
show subpopulations
Gnomad AFR exome
AF:
0.0249
Gnomad AMR exome
AF:
0.130
Gnomad ASJ exome
AF:
0.135
Gnomad EAS exome
AF:
0.262
Gnomad FIN exome
AF:
0.140
Gnomad NFE exome
AF:
0.148
Gnomad OTH exome
AF:
0.150
GnomAD4 exome
AF:
0.155
AC:
224757
AN:
1448424
Hom.:
19881
Cov.:
30
AF XY:
0.160
AC XY:
115644
AN XY:
721378
show subpopulations
African (AFR)
AF:
0.0202
AC:
669
AN:
33192
American (AMR)
AF:
0.129
AC:
5765
AN:
44654
Ashkenazi Jewish (ASJ)
AF:
0.136
AC:
3538
AN:
26060
East Asian (EAS)
AF:
0.225
AC:
8922
AN:
39600
South Asian (SAS)
AF:
0.320
AC:
27459
AN:
85844
European-Finnish (FIN)
AF:
0.142
AC:
7487
AN:
52728
Middle Eastern (MID)
AF:
0.100
AC:
576
AN:
5746
European-Non Finnish (NFE)
AF:
0.146
AC:
161137
AN:
1100632
Other (OTH)
AF:
0.153
AC:
9204
AN:
59968
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.476
Heterozygous variant carriers
0
8393
16786
25179
33572
41965
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
5870
11740
17610
23480
29350
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.120
AC:
18160
AN:
151920
Hom.:
1451
Cov.:
32
AF XY:
0.124
AC XY:
9224
AN XY:
74234
show subpopulations
African (AFR)
AF:
0.0282
AC:
1170
AN:
41464
American (AMR)
AF:
0.127
AC:
1937
AN:
15260
Ashkenazi Jewish (ASJ)
AF:
0.129
AC:
448
AN:
3468
East Asian (EAS)
AF:
0.258
AC:
1331
AN:
5156
South Asian (SAS)
AF:
0.344
AC:
1653
AN:
4810
European-Finnish (FIN)
AF:
0.140
AC:
1470
AN:
10504
Middle Eastern (MID)
AF:
0.0753
AC:
22
AN:
292
European-Non Finnish (NFE)
AF:
0.144
AC:
9768
AN:
67944
Other (OTH)
AF:
0.118
AC:
248
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
774
1548
2321
3095
3869
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
224
448
672
896
1120
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.140
Hom.:
3101
Bravo
AF:
0.110
Asia WGS
AF:
0.281
AC:
978
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:5
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

6-Pyruvoyl-tetrahydrobiopterin synthase deficiency Benign:3
Feb 04, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Jan 13, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

Jul 01, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Mar 03, 2015
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.85
CADD
Benign
9.5
DANN
Benign
0.81
PhyloP100
0.19
PromoterAI
-0.0062
Neutral
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.1
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs3819331; hg19: chr11-112099410; COSMIC: COSV54785665; COSMIC: COSV54785665; API